Telix Pharmaceuticals Limited (TLPPF)
OTCMKTS
· Delayed Price · Currency is USD
16.50
-0.20 (-1.20%)
Jan 21, 2025, 4:00 PM EST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $5.63 billion as of January 22, 2025. Its market cap has increased by 165.82% in one year.
Market Cap
5.63B
Enterprise Value
5.57B
Revenue
430.80M
Ranking
n/a
PE Ratio
171.55
Stock Price
$16.50
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 115.28M to 5.63B, an increase of 4,783.71%. That is a compound annual growth rate of 71.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.99B |
| Veradigm | 1.54B |
| SS Innovations International | 1.46B |
| Nika Pharmaceuticals | 603.98M |
| Elite Pharmaceuticals | 526.28M |
| Glass House Brands | 431.12M |
| Northwest Biotherapeutics | 367.83M |
| BioStem Technologies | 264.80M |